CLSN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 4.66%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Imunon Insider Trading History Chart

Imunon Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 09/20/2022 04:59 PM ET

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Imunon Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/12/2022	Michael H Tardugno	CEO	Buy	4,000	$3.53	$14,120.00	16,513
4/8/2022	Frederick J. Fritz	Director	Buy	5,000	$4.05	$20,250.00	11,766
3/2/2022	Frederick J. Fritz	Director	Buy	2,000	$4.69	$9,380.00
10/7/2021	Frederick J. Fritz	Director	Buy	20,000	$0.88	$17,600.00
5/17/2021	Donald P. Braun	Director	Buy	5,000	$1.07	$5,350.00	5,357

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

Claim your free seat by clicking here now.

SEC Filings (Institutional Ownership Changes) for Imunon (NASDAQ:CLSN)

12.97% of Imunon stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Imunon Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Renaissance Technologies LLC	52,311	$96K	0.0%	+97.0%	0.737%
5/16/2022	State Street Corp	14,303	$72K	0.0%	-93.3%	0.248%
5/13/2022	Renaissance Technologies LLC	26,555	$0.13M	0.0%	-75.6%	0.460%
5/13/2022	Vanguard Group Inc.	234,953	$1.19M	0.0%	-94.0%	4.072%
5/12/2022	BlackRock Inc.	74,918	$0.38M	0.0%	-93.3%	1.298%
2/14/2022	GSA Capital Partners LLP	133,006	$72K	0.0%	+435.2%	0.154%
2/1/2022	FNY Investment Advisers LLC	65,000	$35K	0.0%	N/A	0.075%
1/10/2022	FNY Investment Advisers LLC	65,000	$35K	0.0%	N/A	0.075%
11/9/2021	BlackRock Inc.	1,100,256	$1.02M	0.0%	-1.1%	1.271%
9/17/2021	Virtu Financial LLC	23,341	$30K	0.0%	-76.7%	0.027%
8/16/2021	Charles Schwab Investment Management Inc.	49,041	$63K	0.0%	+185.2%	0.057%
8/16/2021	State Street Corp	214,568	$0.27M	0.0%	N/A	0.248%
8/13/2021	Renaissance Technologies LLC	339,609	$0.43M	0.0%	N/A	0.392%
8/13/2021	Northern Trust Corp	138,646	$0.18M	0.0%	+15.4%	0.160%
8/13/2021	Geode Capital Management LLC	702,100	$0.89M	0.0%	+36.3%	0.811%
8/13/2021	Vanguard Group Inc.	3,678,489	$4.67M	0.0%	+17.8%	4.250%
5/19/2021	Virtu Financial LLC	99,993	$0.14M	0.0%	N/A	0.116%
5/19/2021	Squarepoint Ops LLC	103,658	$0.14M	0.0%	-22.0%	0.120%
5/18/2021	Morgan Stanley	1,942,193	$2.68M	0.0%	+17,570.8%	2.244%
5/18/2021	Jane Street Group LLC	19,243	$27K	0.0%	N/A	0.022%
5/17/2021	Eudaimonia Partners LLC	150,300	$0.21M	0.0%	+20.2%	0.174%
5/17/2021	HRT Financial LP	47,163	$65K	0.0%	N/A	0.054%
5/14/2021	XTX Topco Ltd	50,663	$70K	0.0%	N/A	0.059%
5/13/2021	Barclays PLC	21,353	$29K	0.0%	N/A	0.025%
5/12/2021	Northern Trust Corp	120,149	$0.17M	0.0%	+72.2%	0.139%
5/12/2021	Geode Capital Management LLC	514,955	$0.71M	0.0%	+110.8%	0.595%
5/7/2021	BlackRock Inc.	1,133,257	$1.56M	0.0%	+59.8%	1.309%
5/6/2021	Altium Capital Management LP	3,496,154	$4.83M	1.3%	N/A	4.039%
2/18/2021	Eudaimonia Partners LLC	125,000	$89K	0.0%	+19.0%	0.334%
2/16/2021	Squarepoint Ops LLC	132,873	$94K	0.0%	N/A	0.355%
2/4/2021	GSA Capital Partners LLP	266,603	$0.19M	0.0%	+69.4%	0.712%
12/11/2020	Virtu Financial LLC	167,489	$0.12M	0.0%	N/A	0.448%
11/23/2020	Eudaimonia Partners LLC	105,000	$77K	0.0%	+23.5%	0.281%
11/17/2020	Jane Street Group LLC	46,003	$34K	0.0%	N/A	0.127%
11/13/2020	Morgan Stanley	674,883	$0.49M	0.0%	+161,355.3%	1.866%
11/6/2020	GSA Capital Partners LLP	157,427	$0.12M	0.0%	N/A	0.435%
9/15/2020	Two Sigma Advisers LP	13,200	$49K	0.0%	N/A	0.040%
8/20/2020	Charles Schwab Investment Management Inc.	17,195	$64K	0.0%	N/A	0.052%
8/14/2020	Worth Venture Partners LLC	178,500	$0.66M	0.3%	N/A	0.537%
7/30/2020	Park Avenue Securities LLC	25,000	$93K	0.0%	N/A	0.078%
7/29/2020	Total Investment Management Inc.	24,000	$89K	0.0%	N/A	0.075%
7/8/2020	Envestnet Asset Management Inc.	25,000	$93K	0.0%	N/A	0.078%
5/5/2020	Eudaimonia Partners LLC	85,000	$77K	0.0%	+70.0%	0.291%

Data available starting January 2016

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.